Stem Cell Manufacturing Market

Thermo Fisher Scientific (US) and Merck Millipore (Germany) are the Key Players in the Stem Cell Manufacturing Market

The stem cell manufacturing market is projected to reach USD 18.0 billion by 2026 from USD 11.5 billion in 2021, at a CAGR of 9.4% during the forecast period. The growth of this market is mainly driven by growing venture capital funding in stem cell-based research, rising awareness about the therapeutic potency of stem cell products, increased market focus on embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), and supportive regulatory framework across developing countries.

The prominent players operating in the stem cell manufacturing market are Thermo Fisher Scientific (US), Merck Millipore (Germany), Lonza Group AG (Switzerland), Danaher Corporation (US), and Sartorius AG (Germany).

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific (US) held the leading position in the stem cell manufacturing market in 2020. It will continue to have a strong market position owing to its robust offerings in stem cell lines, instruments, and consumables. The company also has a significant geographic presence. The company adopts organic and inorganic strategies such as acquisitions, product launches, and expansions to strengthen its market position. For instance, in October 2018, Thermo Fisher Scientific acquired BD’s advanced bioprocessing business and expanded its cell culture media products and bioproduction portfolio.

Merck Millipore (Germany) held the second position in the stem cell manufacturing market in 2020. The company adopted organic and inorganic strategies such as acquisitions, product launches, and collaborations to gain a prominent position in the market. Some of its recent launches include the Scepter 3.0 handheld automated cell counter (2020) and the CellStream benchtop flow cytometry system (2018). Additionally, it also collaborated with Genscript (China) and genOway (France) and significantly expanded its geographic footprint as well.

Related Reports:

Stem Cell Manufacturing Market by Product (Consumables, Instrument, HSCs, MSCs, iPSCs, ESCs), Application (Research, Clinical {Autologous, Allogenic}, Cell & Tissue Banking), End User (Pharma & Biotech, Hospitals, Tissue Bank) - Global Forecast to 2026

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
BT 6089
RI Published ON
5/18/2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Stem Cell Manufacturing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved